Intera Atlas
Run match
Sites / Texas Diabetes & Endocrinology
Is this you?

Request access for Texas Diabetes & Endocrinology with your @texasdiabetes.com work email. Intera will contact you to verify and set up your account — nothing auto-publishes.

Request account

Texas Diabetes & Endocrinology

Unclaimed profile

Site Network · Austin, Texas · ~2 sites

WebsiteRank for protocol
Intera lens
ICP 8Lift (cardio sample) 0.71Recruit soph 0.29
Quality Scorecard (1–100)
Overall77Recruit65Ops83Sponsor83Ther76

Performance (observed)

Historical trials
350
Completed
220
Terminated/Withdrawn
33
Completion rate
87%
Active now
92
Phase 2
101
Phase 3
191
Realized enrollment
486,359
First study year
1994
Years active
32
Match confidence
high
Enrollment velocity (inf)
15,199

Therapeutic

Areas
Diabetes (Type 1 & 2), Endocrinology, Obesity, Weight management, Thyroid disorders, Osteoporosis, Metabolic disorders, Cardiovascular disease (cardiometabolic emphasis)
Specialties
Diabetes (Type 1 & 2), Thyroid, Osteoporosis, Weight Management, Cardiometabolic, Alzheimer's
Breadth (conditions)
156
Languages
English, Unknown others
States
Texas

Recruitment (web observed)

Recruitment pages
Yes
Advertises recruitment
Yes
SEO
Y (Active blog content, clinical trial education pages)
Capability notes
Multi-location research (3 locations across Central Texas); recognized as one of top endocrine research sites worldwide; compensated trial participation; extensive patient population

Relationships

Sponsors
Eli Lilly and Company; Novo Nordisk A/S; Boehringer Ingelheim; Medtronic MiniMed, Inc.; Pfizer; Mannkind Corporation
CROs
Covance; Ergomed; ICON Clinical Research; Lexicon Pharmaceuticals; Medpace, Inc.; PPD Development, LP
Owner / parent
Private clinical practice; board-certified endocrinologists and advanced practice providers
Recent hiring
Y (Active recruitment, recent blog posts 2024)

Capacity & people

Investigators
—
Coordinators
—
Emails
Thomas.blevins@texasdiabetes.com

Tech & DCT

EHR
Unknown (secure patient portal present)
Builds tech
Vendors (patient portal, diagnostic systems)
DCT / decentralized
N (3 Central Texas locations)
Tech stack
Patient portal; secure record access; in-house diagnostics and imaging
Recruiting visible
Y

Notes

Multi-site endocrinology research network with 6 active recruiting cardiometabolic trials confirmed (ClinicalTrials.gov validation). Recognized as one of top endocrine research sites globally. Strong cardiometabolic therapeutic focus (diabetes, obesity, endocrine metabolic conditions). Multi-location infrastructure in Central Texas. Experienced research department with emphasis on patient outcomes and medical advancement. Score reflects: multiple sites, high-volume cardiometabolic specialization, global research recognition, strong recruitment infrastructure, specialized endocrinology expertise; limited public visibility on leadership and technology details.

Recommendation features (sample indication)

Ind fit 1.00Liftability 0.71Overall77

FUTURE MOAT: absolute enrollment rates, funnel CPR, measured SSU, screen-fail reasons.